From Gaucher's Disease to Metabolic Radiology: Translational Radiological Research and Clinical Practice

ABSTRACT

Imaging has an increasing role in the management of patients with inborn errors of metabolism. This role is related to expensive enzyme replacement therapy that requires a surrogate biomarker, such as magnetic resonance imaging. This review paper raises the issue of the potential for metabolic radiology to become a subspecialty.

Metabolic radiology - Gaucher's disease - Morquio syndrome

REFERENCES

• 1 Beutler E, Grabowski G A. Glucosylceramide liposes: Gaucher disease. In: Sciver C R, Beaudet A L, Sly W S, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. New York, NY: McGraw-Hill; 1995: 2641-2670
• 2 Rosenthal D I, Scott J A, Barranger J et al.. Evaluation of Gaucher disease using magnetic resonance imaging.  J Bone Joint Surg Am. 1986;  68 (6) 802-808
• 3 Lanir A, Hadar H, Cohen I et al.. Gaucher disease: assessment with MR imaging.  Radiology. 1986;  161 (1) 239-244
• 4 O'Keefe D, Rosenthal D I. Computed tomography and magnetic resonance imaging in Gaucher's disease. In: Bloem J L, Sartoris D J, eds. MRI and CT of the Musculoskeletal System: A Text-Atlas. Baltimore, MD: William & Wilkins; 1992: 130
• 5 Rosenthal D I, Barton N W, McKusick K A et al.. Quantitative imaging of Gaucher disease.  Radiology. 1992;  185 (3) 841-845
• 6 Vogler III J B, Murphy W A. Bone marrow imaging.  Radiology. 1988;  168 (3) 679-693
• 7 Nyce J M, Steele J S, Gunderman R B. Bridging the knowledge divide in radiology education.  Radiology. 2006;  239 (3) 629-631
• 8 Dixon W T. Simple proton spectroscopic imaging.  Radiology. 1984;  153 (1) 189-194
• 9 Miller S P, Zirzow G C, Doppelt S H, Brady R O, Barton N W. Analysis of the lipids of normal and Gaucher bone marrow.  J Lab Clin Med. 1996;  127 (4) 353-358
• 10 Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.  Blood Cells Mol Dis. 2001;  27 (6) 1005-1012
• 11 Johnson L A, Hoppel B E, Gerard E L et al.. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.  Radiology. 1992;  182 (2) 451-455
• 12 Maas M, Akkerman E M, Venema H W, Stoker J, Den Heeten G J. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.  J Comput Assist Tomogr. 2001;  25 (5) 691-697
• 13 Rosen B R, Fleming D M, Kushner D C et al.. Hematologic bone marrow disorders: quantitative chemical shift MR imaging.  Radiology. 1988;  169 (3) 799-804
• 14 Akkerman E M, Maas M. A region-growing algorithm to simultaneously remove dephasing influences and separate fat and water in two-point Dixon imaging.  Paper presented at: Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology Meeting; 1995; Berkeley, California
• 15 Maas M, Hollak C E, Akkerman E M, Aerts J F. Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.  JBR-BTR. 2006;  89 (6) 318-321
• 16 Maas M, Hollak C E, Akkerman E M, Aerts J M, Stoker J, Den Heeten G J. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.  AJR Am J Roentgenol. 2002;  179 (4) 961-965
• 17 Boomsma J M, van Dussen L, Wiersma M G et al.. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.  Blood Cells Mol Dis. 2010;  44 (3) 181-187
• 18 Cox T M, Aerts J M, Belmatoug N et al.. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.  J Inherit Metab Dis. 2008;  31 (3) 319-336
• 19 Vom Dahl S, Poll L, Di Rocco M et al.. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients.  Curr Med Res Opin. 2006;  22 (6) 1045-1064
• 20 Aerts J M, van Breemen M J, Bussink A P et al.. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.  Acta Paediatr Suppl. 2008;  97 (457) 7-14
• 21 Maas M, Hangartner T, Mariani G et al.. Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease.  Skeletal Radiol. 2008;  37 (3) 185-188
• 22 Vanhoenacker F M, Maas M. Guidelines for Belgian MR centers for monitoring of bone marrow involvement in patients with Gaucher disease.  JBR-BTR. 2006;  89 (6) 321-324
• 23 Poll L W, Cox M L, Godehardt E, Steinhof V, vom Dahl S. Whole body MRI in type I Gaucher patients: evaluation of skeletal involvement.  Blood Cells Mol Dis. 2011;  46 (1) 53-59
• 24 Robertson P L, Maas M, Goldblatt J. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.  AJR Am J Roentgenol. 2007;  188 (6) 1521-1528
• 25 Maas M, van Kuijk C, Stoker J et al.. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience.  Radiology. 2003;  229 (2) 554-561
• 26 de Fost M, Hollak C E, Groener J E et al.. Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.  Blood. 2006;  108 (3) 830-835
• 27 DeMayo R F, Haims A H, McRae M C, Yang R, Mistry P K. Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease.  AJR Am J Roentgenol. 2008;  191 (1) 115-123
• 28 SPHINX Amsterdam Lysosome Center. Mission statement. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.nl/index.cfm?pid=8626 Accessed February 4, 2011
• 29 SPHINX Amsterdam Lysosome Center. Education program. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.nl/index.cfm?pid=9327 Accessed January 16, 2011
• 30 Garrod A. The incidence of alkaptonuria: a study in chemical individuality.  Lancet. 1902;  2 1616-1620
• 31 C.E.M. Hollak: Who is who in research: AMC. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.uva.nl/?pid=6454&rm=person&medewerkerid=446 Accessed February 6, 2011
• 32 Professor Carla Hollak receives the sixth Alan Gordon Memorial Award. Gauchers Association Web site. Available at: http://www.gaucher.org.uk/enews.php?id=326 Accessed January 12, 2011
• 33 Hendriksz C J. Inborn errors of metabolism for the diagnostic radiologist.  Pediatr Radiol. 2009;  39 (3) 211-220
• 34 Northover H, Cowie R A, Wraith J E. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review.  J Inherit Metab Dis. 1996;  19 (3) 357-365
• 35 Dvorak-Ewell M, Wendt D, Hague C et al.. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.  PLoS ONE. 2010;  5 (8) e12194
• 36 Bashir A, Gray M L, Hartke J, Burstein D. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI.  Magn Reson Med. 1999;  41 (5) 857-865
• 37 Burstein D, Gray M, Mosher T, Dardzinski B. Measures of molecular composition and structure in osteoarthritis.  Radiol Clin North Am. 2009;  47 (4) 675-686
• 38 Gray M L, Burstein D, Kim Y J, Maroudas A. 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications.  J Orthop Res. 2008;  26 (3) 281-291
• 39 Lohmander L S. Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.  J Anat. 1994;  184 (Pt 3) 477-492
• 40 Keshari K R, Lotz J C, Kurhanewicz J, Majumdar S. Correlation of HR-MAS spectroscopy derived metabolite concentrations with collagen and proteoglycan levels and Thompson grade in the degenerative disc.  Spine (Phila Pa 1976). 2005;  30 (23) 2683-2688
• 41 Zuo J, Saadat E, Romero A et al.. Assessment of intervertebral disc degeneration with magnetic resonance single-voxel spectroscopy.  Magn Reson Med. 2009;  62 (5) 1140-1146
• 42 Urban J P, McMullin J F. Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration.  Spine (Phila Pa 1976). 1988;  13 (2) 179-187
• 43 Antoniou J, Steffen T, Nelson F et al.. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.  J Clin Invest. 1996;  98 (4) 996-1003